Insider sales are immaterial relative to market cap and likely driven by routine portfolio diversification or tax planning. The CFO's $762K sale is a single transaction at a $39.9B market cap, no bearish signal. Monitor for any upcoming data readouts or regulatory catalysts that could drive the stock, but this cluster has no actionable trading edge.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 2 $189.24entry
- T+1 · 4mo ago +0.40%α −0.48% · $189.99
- T+5 · 4mo ago −1.25%α −2.61% · $186.88
- T+20 · 4mo ago −0.90%α −1.21% · $187.53
- T+60 · 7w ago +6.61%α +3.81% · $201.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Revolution Medicines sold a total of $817K in stock over a 7-day window. CFO Jack Anders sold $762K (4.6K shares at $167.34) and Director Patel Sushil sold $55K (300 shares at $183.17) after exercising options. The total sales represent ~0.002% of the $39.9B market cap, a trivial amount with no material signal.
Key Financial Metrics
Key Facts
- CFO Jack Anders sold $762K worth of RVMD stock on 2026-06-24 at $167.34/share
- Director Patel Sushil sold $55K worth of RVMD stock on 2026-06-29 at $183.17/share
- Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap
- Patel Sushil also exercised options for 2,955 shares at $37.54/share on 2026-06-29
- No open-market insider purchases in the cluster window
Financial Impact
Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap, a trivial amount
Risk Factors
- Insider sales could accelerate if stock continues to appreciate
- No open-market purchases to signal insider conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RVMD-1782976983692 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers